Are Wardwizard Inno. latest results good or bad?
Wardwizard Innovations & Mobility's latest results show significant growth in profit and sales, with a PBT of Rs 9.56 crore and net sales of Rs 109.07 crore. However, rising interest costs and a higher debt-equity ratio indicate financial challenges, leading to a mixed evaluation of their performance.
Wardwizard Innovations & Mobility has reported its financial results for the quarter ending March 2025, showcasing notable operational trends. The company achieved a Profit Before Tax (PBT) of Rs 9.56 crore, which represents a substantial growth compared to the average PBT of Rs 1.55 crore over the last four quarters. Similarly, the Profit After Tax (PAT) reached Rs 6.45 crore, reflecting a significant increase from the previous average of Rs 0.97 crore.Net sales for the quarter amounted to Rs 109.07 crore, indicating a rise from the average of Rs 80.99 crore in the prior four quarters. The operating profit also reached a five-quarter high at Rs 18.73 crore, with an operating profit margin of 17.17%, suggesting enhanced operational efficiency.
However, the company is encountering challenges, such as a rising interest cost of Rs 13.72 crore, which has seen a notable increase over the previous half-year. Additionally, the debt-equity ratio has escalated to 1.90 times, the highest in five half-year periods, indicating increased borrowing. The debtors turnover ratio has declined to 1.96 times, pointing to slower settlement of receivables.
In light of these results, the company saw an adjustment in its evaluation, reflecting the mixed operational trends observed during the reporting period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
